Brief: Myriad Genetics Q2 Operating Income USD -113.7 Million
03/08/2023 21:05
Aug 03 (Reuters) - Myriad Genetics Q2 gross margin 68.5%. * Q2 adjusted operating income USD -6.8 million * Q2 adjusted operating expenses USD 133.4 million * Q2 operating expenses USD 239.4 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple